Rate and predictors of insufficient sweat volume in very young infants after pilocarpine gel iontophoresis: prospective, population-based study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 38253430.
- Also identified by DOI 10.1136/archdischild-2023-326487.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To verify the rate and predictors of 'quantity not sufficient' (QNS) among Brazilian infants younger than 3 months with positive newborn screening (NBS) for cystic fibrosis (CF). Prospective, population-based study. Public Statewide Newborn Screening Programme where the incidence rate of CF is ≈1:11 000. Subjects with positive two-tiered immunoreactive trypsinogen. Sweat induction and collection were performed in the same facility; one sweat sample was obtained per individual. The QNS rate and its predictors; analysis corresponded to the day of sweat collection. Among the 975 participants, QNS rates for 10 and 15 µL were 3.6% (95% CI 2.5% to 4.9%) and 8.3% (95% CI 6.6% to 10.2%). Infants weighing >3056 and >3845 g and with gestational age higher than 37 weeks had a greater likelihood (5.5 and 6.7, and 2.7 and 5.8 times more, respectively) of avoiding QNS than their peers. QNS rates fulfilled the requirements, but predictors differed from those recommended by the Cystic Fibrosis Foundations guidelines.
Medical subject headings
- Pilocarpine
- Cystic Fibrosis